scholarly journals Tumor Volume Decrease at 8 Weeks Is Associated with Longer Survival in EGFR-Mutant Advanced Non–Small-Cell Lung Cancer Patients Treated with EGFR TKI

2013 ◽  
Vol 8 (8) ◽  
pp. 1059-1068 ◽  
Author(s):  
Mizuki Nishino ◽  
Suzanne E. Dahlberg ◽  
Stephanie Cardarella ◽  
David M. Jackman ◽  
Michael S. Rabin ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Tumor Volume ◽  
Small Cell ◽  
Small Cell Lung ◽  
Lung Cancer Patients ◽  
Egfr Mutant ◽  
Egfr Tki ◽  
Volume Decrease

Beyond EGFR TKI in EGFR-mutant Non-Small Cell Lung Cancer patients: Main challenges still to be overcome

2014 ◽  
Vol 40 (6) ◽  
pp. 723-729 ◽  
Author(s):  
J. Remon ◽  
T. Morán ◽  
N. Reguart ◽  
M. Majem ◽  
E. Carcereny ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Lung Cancer Patients ◽  
Egfr Mutant ◽  
Egfr Tki

19P Predictors of osimertinib response at second-line treatment in EGFR mutant non-small cell lung cancer patients with acquired T790M resistance mutation

2021 ◽  
Vol 32 ◽  
pp. S1351
Author(s):  
I. Dogan ◽  
M. Gürbüz ◽  
N. Paksoy ◽  
N. Khanmamadov ◽  
S. Vatansever ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Resistance Mutation ◽  
Small Cell ◽  
Line Treatment ◽  
Second Line ◽  
Small Cell Lung ◽  
Lung Cancer Patients ◽  
Egfr Mutant

scholarly journals EP1.01-05 EGFR-2013-CPHG, a Real-World Study of EGFR Mutant Advanced Non-Small-Cell Lung Cancer Patients Treated with Erlotinib

2019 ◽  
Vol 14 (10) ◽  
pp. S916
Author(s):  
D. Debieuvre ◽  
J. Tredaniel ◽  
L. Moreau ◽  
S. Larivé ◽  
J. Le Treut ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Real World ◽  
Small Cell ◽  
Small Cell Lung ◽  
Lung Cancer Patients ◽  
Egfr Mutant

Continuous EGFR-TKI administration following radiotherapy for non-small cell lung cancer patients with isolated CNS failure

Lung Cancer ◽  
2011 ◽  
Vol 74 (3) ◽  
pp. 457-461 ◽  
Author(s):  
Takehito Shukuya ◽  
Toshiaki Takahashi ◽  
Tateaki Naito ◽  
Rieko Kaira ◽  
Akira Ono ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Lung Cancer Patients ◽  
Egfr Tki

Re-biopsy in advanced non-small cell lung cancer patients after the development of 3rd generation EGFR-TKI and new targeted therapies.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. e19081-e19081 ◽  
Author(s):  
Kaname Nosaki ◽  
Eiko Inamasu ◽  
Shin-ichiro Shimamatsu ◽  
Tsukihisa Yoshida ◽  
Goji Toyokawa ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Targeted Therapies ◽  
Small Cell ◽  
Small Cell Lung ◽  
Lung Cancer Patients ◽  
Egfr Tki

scholarly journals P2.03-055 Comparison of Afatinib Versus Erlotinib for Advanced Non-Small-Cell Lung Cancer Patients with Resistance to EGFR-TKI

2017 ◽  
Vol 12 (11) ◽  
pp. S2396
Author(s):  
Y. Sakamori ◽  
Y. Yasuda ◽  
T. Funazo ◽  
T. Nomizo ◽  
T. Tsuji ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Lung Cancer Patients ◽  
Egfr Tki
Sign in / Sign up

Export Citation Format

Share Document